Treatment of hyperlipoproteinaemia type II a with a new anion exchange resin Secholex®
- 1 January 1974
- journal article
- clinical trial
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 7 (1) , 65-69
- https://doi.org/10.1007/bf00614393
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Drug treatment of lipoproteinaemia type II. Effect on plasma lipids of a new phenoxyacetic acid derivative, clofibrate, and nicotinic acidEuropean Journal of Clinical Pharmacology, 1973
- Colestipol and cholestyramine resin. Comparative effects in familial type II hyperlipoproteinemiaJAMA, 1972
- Combined Use of Clofibrate and Cholestyramine or DEAE Sephadex in HypercholesterolaemiaBMJ, 1971
- TREATMENT OF ESSENTIAL HYPERLIPIDÆMIAThe Lancet, 1970
- Treatment of hyperlipidemiasThe American Journal of Medicine, 1968
- Lipoprotein-elektrophorese in agarosegelClinica Chimica Acta; International Journal of Clinical Chemistry, 1968
- Metabolism of Orally Administered Dextran and ‘Sephadex’ Derivatives in the RatNature, 1967
- Treatment of Hypercholesterolemia and Hypertriglyceridemia by Anion Exchange ResinSouthern Medical Journal, 1966
- An Evaluation of the Theorell Method for the Determination of Total Serum CholesterolScandinavian Journal of Clinical and Laboratory Investigation, 1959
- Evaluation of the P-Toluene-Sulfonic Acid Method for Quantitative Determination of Total Cholesterol in SerumScandinavian Journal of Clinical and Laboratory Investigation, 1956